Please login to the form below

Not currently logged in
Email:
Password:

Pipeline

This page shows the latest Pipeline news and features for those working in and with pharma, biotech and healthcare.

Lilly partners with AC Immune on tau drug for Alzheimer’s

Lilly partners with AC Immune on tau drug for Alzheimer’s

including Lilly’s own amyloid-targeting solanezumab and lanabecestat – have failed in clinical trials, although the former remains in Lilly’s pipeline.

Latest news

More from news
Approximately 14 fully matching, plus 1,563 partially matching documents found.

Latest Intelligence

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    A study published earlier this year found that the proportion of pipeline molecules at the unit that moved from preclinical investigation to completion of phase 3 trials rose from 4% to ... She has truly had a significant impact on transforming

  • Deal Watch October 2018

    Acquisition. $2B. Tango Therapeutics/. Gilead Sciences. Pipeline of up to 5 targeted immuno‐oncology. ... Finally, following a full pipeline review, Novartis has reduced its drug programmes from 430 to 340, leaving 90 products adrift, many of which may

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    Pipeline problems. The Commission’s novel approach has its roots in pharma mergers. ... Focusing on pipeline products is no longer enough to assess the regulatory risks posed by a transaction.

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    I look forward to working with these outstanding leaders to achieve the full potential of our pipeline and deliver our next stage of growth.”. ... Nevertheless, despite this and the usual caveats about the unpredictability of drug development, Pfizer

  • Brexit: can pharma 'take back control' of the narrative? Brexit: can pharma 'take back control' of the narrative?

    world-leading life sciences status, it is crucial to develop a strategic approach in developing a skills pipeline for the entire Life Sciences sector”.  .

More from intelligence
Approximately 1 fully matching, plus 130 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 176 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 32 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics